AAAAAA

   
Results: 1-8 |
Results: 8
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
Authors: Xiang, R Silletti, S Lode, HN Dolman, CS Ruehlmann, JM Niethammer, AG Pertl, U Gillies, SD Primus, FJ Reisfeld, RA
Citation: R. Xiang et al., Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice, CLIN CANC R, 7(3), 2001, pp. 856S-864S
Production of functional antibodies generated in a nonlytic insect cell expression system
Authors: Li, EG Brown, SL Dolman, CS Brown, GB Nemerow, GR
Citation: Eg. Li et al., Production of functional antibodies generated in a nonlytic insect cell expression system, PROT EX PUR, 21(1), 2001, pp. 121-128
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
Authors: Niethammer, AG Primus, FJ Xiang, R Dolman, CS Ruehlmann, JM Ba, Y Gillies, SD Reisfeld, RA
Citation: Ag. Niethammer et al., An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice, VACCINE, 20(3-4), 2001, pp. 421-429
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancerin carcinoembryonic antigen-transgenic mice
Authors: Xiang, R Primus, FJ Ruehlmann, JM Niethammer, AG Silletti, S Lode, HN Dolman, CS Gillies, SD Reisfeld, RA
Citation: R. Xiang et al., A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancerin carcinoembryonic antigen-transgenic mice, J IMMUNOL, 167(8), 2001, pp. 4560-4565
MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma
Authors: Ruehlmann, JM Xiang, R Niethammer, AG Ba, Y Perti, U Dolman, CS Gillies, SD Reisfeld, RA
Citation: Jm. Ruehlmann et al., MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma, CANCER RES, 61(23), 2001, pp. 8498-8503
Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma
Authors: Niethammer, AG Xiang, R Ruehlmann, JM Lode, HN Dolman, CS Gillies, SD Reisfeld, RA
Citation: Ag. Niethammer et al., Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma, CANCER RES, 61(16), 2001, pp. 6178-6184
An autologous oral DNA vaccine protects against murine melanoma (vol. 97, pg. 5492, 2000)
Authors: Xiang, R Lode, HN Chao, TH Ruehlmann, JM Dolman, CS Rodriguez, F Whitton, JL Overwijk, WW Restifo, NP Reisfeld, RA
Citation: R. Xiang et al., An autologous oral DNA vaccine protects against murine melanoma (vol. 97, pg. 5492, 2000), P NAS US, 97(23), 2000, pp. 12932-12932
An autologous oral DNA vaccine protects against murine melanoma
Authors: Xiang, R Lode, HN Chao, TH Ruehlmann, JM Dolman, CS Rodriguez, F Whitton, JL Overwijk, WW Restifo, NP Reisfeld, RA
Citation: R. Xiang et al., An autologous oral DNA vaccine protects against murine melanoma, P NAS US, 97(10), 2000, pp. 5492-5497
Risultati: 1-8 |